- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Anterogen Co Ltd (065660)
Anterogen Co Ltd stock price live, this page displays KQ 065660 stock exchange data. View the 065660 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Anterogen Co Ltd real time stock price chart below.
What Is the Anterogen Co Ltd Stock Price Today?
The Anterogen Co Ltd stock price today is 24,400.
What Is the Stock Symbol for Anterogen Co Ltd?
The stock symbol for Anterogen Co Ltd is ""065660.""
What Stock Exchange Does Anterogen Co Ltd Trade On?
Anterogen Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is Anterogen Co Ltd a Good Stock to Buy?
Determining whether Anterogen Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 065660 quote. (ISIN: KR7065660003)
What Is the Anterogen Co Ltd Stock Price Today?
The Anterogen Co Ltd stock price today is 24,400.
What Is the Stock Symbol for Anterogen Co Ltd?
The stock symbol for Anterogen Co Ltd is ""065660.""
What Stock Exchange Does Anterogen Co Ltd Trade On?
Anterogen Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is Anterogen Co Ltd a Good Stock to Buy?
Determining whether Anterogen Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 065660 quote. (ISIN: KR7065660003)
KOSDAQ
Currency in KRW
24,400
-450(-1.81%)
Closed·
Fair Value
An estimate of a Anterogen's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24,400
25,200
52 wk Range
13,700
29,650
065660 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
065660 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Anterogen's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24,40025,200
52 wk Range
13,70029,650
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
065660 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Anterogen's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Biotechnology industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Anterogen Co Ltd Company Profile
Anterogen.Co.,Ltd., a bio-venture company, engages in the research, development, and commercialization of cell therapy products using adipose-derived stem cells in South Korea and internationally. The company offers medicines, including Cupistem injection, an adipose stem cell product that is used for the treatment of Crohn’s fistula; Queencell, a stromal vascular fraction used for the regeneration of subcutaneous adipose tissue; and Remodulin injection, a medicine for the treatment of pulmonary arterial hypertension. It also provides cosmetics, such as hair care products comprising SCM2 and SCM2-Black; and skin care products, such as Therastem-Derma, Therastem-White Silk, and Therastem-White Glutathione, as well as stem cell media program set, a cosmetic raw material. In addition, the company offers stem cell banking services; and analysis services that include sample analysis for clinical studies, as well as conducts biopharmaceutical tests for identification, purity, potency, adventitious virus, etc. Anterogen.Co.,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea.
Compare 065660 to Peers and Sector
Metrics to compare | 065660 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship065660PeersSector | |
|---|---|---|---|---|
P/E Ratio | −122.5x | −6.5x | −0.5x | |
PEG Ratio | −8.12 | 0.00 | 0.00 | |
Price/Book | 2.7x | 2.9x | 2.6x | |
Price / LTM Sales | 34.0x | 19.8x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 38.7% | |
Fair Value Upside | Unlock | 9.2% | 5.0% | Unlock |
Earnings
Latest Release
Jul 30, 2025
EPS / Forecast
-9.00 / --
Revenue / Forecast
1.89B / --
FAQ
What Stock Exchange Does Anterogen Trade On?
Anterogen is listed and trades on the KOSDAQ stock exchange.
What Is the Stock Symbol for Anterogen?
The stock symbol for Anterogen is "065660."
What Is the Anterogen Market Cap?
As of today, Anterogen market cap is 251.65B.
What Is Anterogen's Earnings Per Share (TTM)?
The Anterogen EPS (TTM) is -202.04.
From a Technical Analysis Perspective, Is 065660 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Anterogen Stock Split?
Anterogen has split 0 times.
How Many Employees Does Anterogen Have?
Anterogen has 0 employees.
What is the current trading status of Anterogen (065660)?
As of 27 Aug 2025, Anterogen (065660) is trading at a price of 24,400.00, with a previous close of 24,400.00. The stock has fluctuated within a day range of 24,400.00 to 25,200.00, while its 52-week range spans from 13,700.00 to 29,650.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.